Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
The DOI matches its Crossref record; 299 of the 300 references it cites were found in a registry or an index.
Abstract
Bile acids (BAs) can regulate their own metabolism and transport as well as other key aspects of metabolic homeostasis via dedicated (nuclear and G protein-coupled) receptors. Disrupted BA transport and homeostasis results in the development of cholestatic disorders and contributes to a wide range of liver diseases, including nonalcoholic fatty liver disease and hepatocellular and cholangiocellular carcinoma. Furthermore, impaired BA homeostasis can also affect the intestine, contributing to the pathogenesis of irritable bowel syndrome, inflammatory bowel disease, and colorectal and oesophageal cancer. Here, we provide a summary of the role of BAs and their disrupted homeostasis in the development of gastrointestinal and hepatic disorders and present novel insights on how targeting BA pathways might contribute to novel treatment strategies for these disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional microbial metabolites, such as conjugated bile acids, can activate the farnesoid X receptor, suppressing hepatic stellate cell activation and fibrogenic signaling, thereby ameliorating liver fibrosis105,106.”
From Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming (2026) · cites this paper as [105]
In the citing paper
“Moreover, BAs have the potential to modulate the gut–brain axis by maintaining intestinal homeostasis, as TGR5 and FXR signaling are pivotal regulators of intestinal immune response and barrier function.365,376”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [376]
In the citing paper
“Peroxisome proliferator-activated receptors (PPARs), liver X receptors (LXRs), FXR and THR (particularly THR-β) are the most extensively studied receptors that are targets for therapy.20–22”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [20]
Citations
Cites
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
Cited by
Items 501–537 of 537
Shan, M., Yan, X., & Jiang, Q. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500176
Xiang, H., Xiang, H., Liu, Z., Chen, H., Luo, Z., Guo, S., & Zhang, J. (2026) · Microorganisms · doi:10.3390/microorganisms14092035
Bile acid-based therapeutics: recent advances in bile acid conjugates and derivatives
Seo, M., Lee, J.-H., Yang, S.-B., Ma, G., Lee, H., Han, J., Ryu, Y., & Park, J. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00830-5
Chen, Z., & Peng, T. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1911009
Lin, H., Peng, X.-R., Qin, X., Zhang, H., Pan, X., Lin, W., Chen, R., Zhu, S., Xiong, F., Huang, X., et al. (2026) · European Journal of Pediatrics · doi:10.1007/s00431-026-07403-6
Li, T., Qin, G., Zhu, S., & Yinzhi, D. (2026) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-2026-0095
Temporal metabolic-pool dynamics in ulcerative colitis remission
刘彭浩邦, Zhuo, D., Huang, H., Barbas, C., Schmitt-Kopplin, P., Xu, G., Yang, H., & Guo, N. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.09.069
New approach methodologies for in vitro detection of chemical-induced cholestatic liver injury
Maerten, A., Avîrvarei, A.-C., & Vinken, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04541-6
Liu, J., Sun, K., Liu, H., Zhu, M., Li, C., He, Y., & Qin, L. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70318
Bile acid signaling in health and disease
Fan, Z., He, M., Liang, T., 张必利, Zhao, N., & Li, P. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00603-4
Hamed, A. M., Al-Nouri, D. M., Mahrous, N. S., Bassit, A. S., Abouelella, A., Hassan, A., Mokhtar, G. S., Ahmad, G. M., Osman, A., Hamed, A., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198839
Zhang, W., Matuszek, G., Dolnikowski, G. G., Lamon‐Fava, S., Ausman, L. M., Lichtenstein, A. H., & Matthan, N. R. (2026) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2026.101561
Inverse Association of the Prognostic Nutritional Index With Gallstone Prevalence Among U.S. Adults
Xu, K., Zhang, Z., Dong, H., & 左阿芳 (2026) · International Journal of Clinical Practice · doi:10.1155/ijcp/2529736
Cossette, F.-X. (2026) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/36363
Zhang, Y., Chen, Y., Huang, S., Jiang, L., Wang, Y., Ma, J., Deng, R., Du, J., Xia, L., Ma, Y., et al. (2026) · medRxiv · doi:10.64898/2026.10.18.26365821
Ajugol Improves Liver Fibrosis by Modulating Bile Acid and Arachidonic Acid Metabolism in Mice
Wei, X., Wang, F., Zhang, D., Zhang, L., Xu, F., Chen, G., Zhang, H., Liu, P., Liu, W., & Xu, Y. (2026) · Phytotherapy Research · doi:10.1002/ptr.70488
Yang, F., Tao, J., Li, X., Sun, J. Y., Pang, X., Ma, P., Li, X., & Lu, Y. (2026) · Chemistry & Biodiversity · doi:10.1002/cbdv.71845
Lu, Z., Yuan, X., Zeng, X., Feng, Q., Li, L., Lv, W., Han, W., Deng, Q., Yang, X., Chen, M., et al. (2026) · npj Science of Food · doi:10.1038/s41538-026-01218-3
Chao, R., Zhang, Y., Hao, Y., Zhang, H., Zhang, M., & Sun, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1949645
Lamichhane, G., Giri, S., Lucas, E., Emerson, S. R., Zhang, G., & Kim, Y. (2026) · Food & Function · doi:10.1039/d6fo04549a
Ban, Z., Chen, C., Zhang, Y., Tu, J., Jiang, X., & 谭相端 (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118842
Lal, D., Pandey, H., & Wong, S. H. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.125329
Li, Y., & Liu, J. (2026) · Microorganisms · doi:10.3390/microorganisms14112562
Dudeja, V., Dhanisha, S. S., Suryansh, S., Salcedo-Noriega, M. F., Vaish, U., Tran, A., Bhandari, S., Kannan, A. B., Raikwar, N., Haque, A. R. A., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14112571
From Dysbiosis to Vascular Disease: the Gut Microbiota in Type 2 Diabetes and Atherosclerosis
Pillai, S. S., & Ashraf, A. P. (2026) · Current Atherosclerosis Reports · doi:10.1007/s11883-026-01485-1
Zhang, F., Zhu, C., Li, X., Zhu, Y., Martínez, D. A. S., Dai, Y., Guo, L., & Kong, D. (2026) · iNew Medicine · doi:10.1002/inm3.70083
Chen, P., Liang, Q., Liu, X., Yang, D., Si, Y., Yang, J., Li, X., Zheng, W., & Li, N. (2026) · Microorganisms · doi:10.3390/microorganisms14112606
Du, J., Yang, H., 谷玉新, Wei, C., Song, Z., Sun, L., Li, C., 李敏洁, & Guo, L. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.6c10549
Yang, M., Wang, H., Bukhari, I., Zhao, Y., Huang, H., Yu, Y., Sun, X., Mi, Y., Mei, L., & Zheng, P. (2023) · doi:10.3389/fnut.2023.1121203.s001
Zhao, S., Fu, H., Zhou, T., Cai, M., Huang, Y., Gan, Q., Zhang, C., Qian, C., Wang, J., Zhang, Z., et al. (2022) · doi:10.3389/fimmu.2022.772368.s001
Wang, R., Gan, C., Mao, R., Chen, Y., Yan, R., Li, G., Xiong, T., & Guo, J. (2025) · doi:10.3389/fimmu.2024.1477902.s001
Xiong, Y., Qiao, W., Wang, Q., Li, K., Jin, R., & Zhang, Y. (2024) · doi:10.3389/fimmu.2024.1357496.s001
Hang, L., Wang, E., Feng, Y., Zhou, Y., Meng, Y., Jiang, F., & Yuan, J. (2022) · doi:10.3389/fmicb.2022.1024822.s005
Microbial bile acid deconjugation counters metabolic decline in aging
Machado, A. C. D., Zhong, W., Saran, A., Russell, B. J., Maissy, E., Ramos, S. F., Pinto, A. F. M., Zuniga-Hertz, J. P., Richter, R. A., Chang, M. W., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.10.016
Chang, J., Zhu, J., 陈高羽, Chen, X., Yin, J., Tao, M., Chu, Y., Wang, Y., Zhu, Y., Chen, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1939930
Metadata
- Authors
- Fuchs, C. D., & Trauner, M.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Trauner, Michael
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2022-02-14
- Volume
- 19
- Issue
- 7
- Pages
- 432-450
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4212954224
- Cited by
- 490
- References
- 300
- Citations by year
- 2026: 134 · 2025: 145 · 2024: 111 · 2023: 77 · 2022: 23
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- bile acids, bile acid receptors, nuclear receptors, G protein-coupled receptors, bile acid homeostasis, bile acid transport, cholestasis, non-alcoholic fatty liver disease, hepatocellular carcinoma, cholangiocarcinoma, irritable bowel syndrome, inflammatory bowel disease, colorectal cancer, esophageal cancer
- MeSH terms
- Bile Acids and Salts, Cholestasis, Homeostasis, Humans, Liver, Receptors, G-Protein-Coupled, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.